Navigation Links
Kendle to Share Insights at Drug Information Association 45th Annual Meeting
Date:6/17/2009

CINCINNATI, June 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that several of its executives will present on important industry issues at the Drug Information Association (DIA) 45th Annual Meeting June 21-25, 2009, in San Diego, Calif. Kendle experts will address key topics in clinical development, including regulatory issues in portfolio management, pregnancy registries and risk management, and patient recruitment and retention for pregnancy registries.

Kendle Speakers

    Wednesday, June 24, 3:30-5 p.m., Room 14B
    Managing Development Portfolios in a Safety-Heightened Environment
    William K. Sietsema, PhD
    Vice President, U.S. Regulatory Consulting and Submissions

    Thursday, June 25, 8:30-10 a.m.
    Pregnancy Registries: Perspectives on a Unique Risk Management Tool
    Deborah Covington, DrPH, MS, Senior Director, Late Phase
    Laura F. McKain, MD, Medical Director, Registries and Epidemiology, Late
     Phase

    Poster Presentation
    Pregnancy Exposure Registries: Enhancing Recruitment and Retention
    Deborah Covington, DrPH, MS
    Senior Director, Late Phase

Kendle at Booth #439

Kendle experts will be available for on-site meetings and to discuss the Company's model for consistent quality execution of Phase I-IV clinical development programs and best practices in the development of strategic customer relationships.

In addition to Phase I-IV clinical development capabilities, the Kendle display also will highlight the Company's continued and recent success in delivering consistent quality and building effective site relationships as validated by independent third-party quantitative research. Kendle recently was named the highest-rated top-five CRO in the 2009 CenterWatch Survey of U.S. Investigative Sites. The Company is the only CRO to have been ranked consistently among the top two providers in the 2009, 2008 and 2007 CenterWatch surveys of U.S. and European investigative sites. In addition, according to the "2009 CRO Quality Benchmarking Report" published by Industry Standard Research (ISR), "Kendle delivers the most consistent quality services" as measured by the "Service Variability Index" (SVI), a measurement of consistency, which researchers at ISR identified as the most significant indicator of quality. Kendle's industry-best score was 12.2 (lower score = less variability, and closer to ideal distribution), while the industry average was 25.1. Kendle rated highest among CROs in the areas of CRA Quality, Consistent Quality Delivery, Meeting Project Timelines and Efficient Site Start-up.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
2. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
3. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
4. Kendle Revises Full Year 2008 Guidance
5. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
6. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
7. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
8. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
9. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
10. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
11. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... , ... As a former supermodel known for her timeless beauty, Joan Severance ... women is that she put all the words in her new book, "Manifest Your ... experiences and sparkling sense of humor have inspired her to write a book on ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... become familiar. This makes it difficult for lab operators and management to assess ... to help them identify wasteful or unnecessary actions. , Created with the ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new ... the last decade, student well-being has seriously declined. "When disenfranchised youth from the ... join the Islamic State to turn the historic multi-ethnic and multi-religious powerhouses of ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of ... Chairman of the Board of Directors for CONTACT USA, and former member of the ...
(Date:4/24/2017)... ... 24, 2017 , ... Miami Periodontist and Dental ... Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in Miami ... Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This annual ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 2017 Viverae ® , a leader in ... of IBM ® Watson Campaign Automation, implementing behavioral ... for a personalized experience. Through digital engagement, the platform ... in real time. The enhanced experience drives engagement by ... wherever they are in their journey to health. ...
Breaking Medicine Technology: